Predicting subretinal fluid absorption with machine learning in patients with central serous chorioretinopathy
Fabao Xu1, Yifan Xiang1, Cheng Wan2
1State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-Sen University, Guangzhou, China.
Machine learning accurately predicts subretinal fluid absorption (SFA) in central serous chorioretinopathy (CSC) patients post-laser treatment. This offers ophthalmologists a tool for personalized treatment and follow-up scheduling.
Area of Science:
- Ophthalmology
- Medical Imaging
- Machine Learning
Background:
- Central serous chorioretinopathy (CSC) is a condition affecting vision.
- Subretinal fluid absorption (SFA) is a key indicator of treatment success in CSC.
- Predicting SFA aids in managing patient prognosis and treatment planning.
Purpose of the Study:
- To develop and validate machine learning models for predicting SFA in CSC patients.
- To identify crucial clinical and imaging features influencing SFA.
- To create a simplified model for practical clinical application.
Main Methods:
- Utilized clinical and imaging data from 480 eyes of 461 CSC patients.
- Employed machine learning algorithms including Random Forest and XGBoost for SFA prediction.
- Validated models using internal (ZOC) and external (XEC) datasets.
Main Results:
- Random Forest achieved high internal validation accuracies for SFA prediction at 1, 3, and 6 months.
- XGBoost demonstrated superior performance in external validation across all time points.
- A simplified model using fewer features showed comparable predictive power.
Conclusions:
- Machine learning models can accurately predict long-term SFA in CSC patients.
- The study identifies key features relevant to patient prognosis.
- Findings support individualized treatment and follow-up strategies for CSC management.
More Related Videos
06:16Author Spotlight: Unraveling the Pathogenesis of Age-Related Macular Degeneration and Discovering Potential Therapies
Published on: July 28, 2023
04:09Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
Published on: October 10, 2018
